Arabic Arabic English English French French German German
dark

Oragenics Announce Changes in Management and Board of Directors

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced that on May 2, 2021, Dr. Alan Joslyn resigned as Chief Executive Officer, President and director of Oragenics, Inc. to pursue other opportunities. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Next Post

The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence

Related Posts
Total
0
Share